Mutations of FGFR3, FGFR3–TACC3 and FGFR3–BAIAP2L1 fusion proteins are frequently associated with bladder cancer, while some FGFR3 mutations are also associated with a better prognosis.
Mutations of FGFR3, FGFR3–TACC3 and FGFR3–BAIAP2L1 fusion proteins are frequently connected to bladder cancer, while some FGFR3 mutations also relate to a more favorable outcome. This suggests that these genetic changes may play a role in the development or progression of the disease.